End Stage Liver DIsease study: MAsS
Official title Adverse Outcomes and Mortality in Liver Transplant
ClinicalTrials.gov ID: NCT05477277
What this study is testing
- What it's testing
- The study aims to find out if a specific muscle score from an MRI scan is linked to bad health outcomes in liver transplant candidates.
- Who it's for
- The study is looking for people with end-stage liver disease who are waiting for a liver transplant.
- What's involved
- Participants will have an MRI scan to measure their muscle composition and be followed to see what happens to their health.
- Time commitment
- The source text does not specify the duration or number of visits required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All patients with end-stage liver disease undergoing evaluation for liver transplantation
- Patient clinically indicated for MRI during transplant candidacy evaluation
- Adult
You likely can't join if
- 1\. Contra indication to MRI
The study team makes the final eligibility decision.
Where it is enrolling
- Phoenix, Arizona, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Phoenix, Arizona, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.